362 related articles for article (PubMed ID: 33466656)
1. Stress-Induced Hyperglycaemia in Non-Diabetic Patients with Acute Coronary Syndrome: From Molecular Mechanisms to New Therapeutic Perspectives.
Bellis A; Mauro C; Barbato E; Ceriello A; Cittadini A; Morisco C
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466656
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.
Nauck MA; Meier JJ; Cavender MA; Abd El Aziz M; Drucker DJ
Circulation; 2017 Aug; 136(9):849-870. PubMed ID: 28847797
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms by which GLP-1 RA and DPP-4i induce insulin sensitivity.
Yaribeygi H; Sathyapalan T; Sahebkar A
Life Sci; 2019 Oct; 234():116776. PubMed ID: 31425698
[TBL] [Abstract][Full Text] [Related]
4. Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome.
Weston C; Walker L; Birkhead J;
Heart; 2007 Dec; 93(12):1542-6. PubMed ID: 17502326
[TBL] [Abstract][Full Text] [Related]
5. SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease.
Zou H; Zhou B; Xu G
Cardiovasc Diabetol; 2017 May; 16(1):65. PubMed ID: 28511711
[TBL] [Abstract][Full Text] [Related]
6. Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target?
Anantharaman R; Heatley M; Weston CF
Heart; 2009 May; 95(9):697-703. PubMed ID: 18697807
[TBL] [Abstract][Full Text] [Related]
7. Hyperglycaemia and its therapy during acute coronary syndromes.
Inzucchi SE
Diab Vasc Dis Res; 2008 Nov; 5(4):259. PubMed ID: 18958834
[No Abstract] [Full Text] [Related]
8. Glucagon orchestrates stress-induced hyperglycaemia.
Harp JB; Yancopoulos GD; Gromada J
Diabetes Obes Metab; 2016 Jul; 18(7):648-53. PubMed ID: 27027662
[TBL] [Abstract][Full Text] [Related]
9. Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.
Derosa G; Maffioli P
N Engl J Med; 2016 Mar; 374(11):1095. PubMed ID: 26981947
[No Abstract] [Full Text] [Related]
10. The treament of hyperglycemia in acute ischemic stroke with incretin-based drugs.
Ferrari F; Moretti A; Villa RF
Pharmacol Res; 2020 Oct; 160():105018. PubMed ID: 32574826
[TBL] [Abstract][Full Text] [Related]
11. Review of insulin treatment in stress-related hyperglycaemia in children without preexisting diabetes.
Ng SM; Balmuri S
Acta Paediatr; 2014 Jan; 103(1):6-9. PubMed ID: 24118012
[TBL] [Abstract][Full Text] [Related]
12. Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus.
Frandsen CS; Dejgaard TF; Madsbad S
Lancet Diabetes Endocrinol; 2016 Sep; 4(9):766-780. PubMed ID: 26969516
[TBL] [Abstract][Full Text] [Related]
13. Add-on therapy in metformin-treated patients with type 2 diabetes at moderate cardiovascular risk: a nationwide study.
Thein D; Christiansen MN; Mogensen UM; Bundgaard JS; Rørth R; Madelaire C; Fosbøl EL; Schou M; Torp-Pedersen C; Gislason G; Køber L; Kristensen SL
Cardiovasc Diabetol; 2020 Jul; 19(1):107. PubMed ID: 32631337
[TBL] [Abstract][Full Text] [Related]
14. Impairment of GLP1-induced insulin secretion: role of genetic background, insulin resistance and hyperglycaemia.
Herzberg-Schäfer S; Heni M; Stefan N; Häring HU; Fritsche A
Diabetes Obes Metab; 2012 Oct; 14 Suppl 3():85-90. PubMed ID: 22928568
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes.
Dandona P; Chaudhuri A; Ghanim H; Mohanty P
Rev Cardiovasc Med; 2006; 7 Suppl 2():S25-34. PubMed ID: 17224874
[TBL] [Abstract][Full Text] [Related]
16. Detrimental Effects of Hyperglycemia in Acute Coronary Syndromes: from Pathophysiological Mechanisms to Therapeutic Strategies.
Angeli F; Reboldi G; Poltronieri C; Aita A; Bartolini C; Verdecchia P
Mini Rev Med Chem; 2015; 15(14):1164-73. PubMed ID: 26202190
[TBL] [Abstract][Full Text] [Related]
17. Second line therapy: type 2 diabetic subjects failing on metformin GLP-1/DPP-IV inhibitors versus sulphonylurea/insulin: for GLP-1/DPP-IV inhibitors.
Kumar A
Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():21-5. PubMed ID: 23280862
[TBL] [Abstract][Full Text] [Related]
18. Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection.
Bielka W; Przezak A; Pawlik A
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299225
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic glucose-dependent insulinotropic polypeptide (GIP) (1-30) expression is upregulated in diabetes and PEGylated GIP(1-30) can suppress the progression of low-dose-STZ-induced hyperglycaemia in mice.
Yanagimachi T; Fujita Y; Takeda Y; Honjo J; Atageldiyeva KK; Takiyama Y; Abiko A; Makino Y; Kieffer TJ; Haneda M
Diabetologia; 2016 Mar; 59(3):533-41. PubMed ID: 26693710
[TBL] [Abstract][Full Text] [Related]
20. Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points.
Goyal A; Nerenberg K; Gerstein HC; Umpierrez G; Wilson PW
Diab Vasc Dis Res; 2008 Nov; 5(4):276-84. PubMed ID: 18958837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
